Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIronveld Regulatory News (IRON)

Share Price Information for Ironveld (IRON)

Share Price is delayed by 15 minutes
Get Live Data
0.021    -0.002 (-8.70%)
Bid:
0.02
Ask:
0.022
Spread: 0.002 (10.00%)
Market Cap: £4.35m
IRON Live PriceLast checked at - London Stock Exchange

Intraday Ironveld Share Chart

Board Appointment

5 Jun 2023 07:00

RNS Number : 5549B
Ironveld PLC
05 June 2023
 

Ironveld Plc ("Ironveld" or the "Company")

Board Appointment

Ironveld plc ("Ironveld" or the "Company"), the AIM quoted mining development company, is pleased to announce the appointment of Ms Malebo Ratlhagane as Deputy Group CFO and to the Board of Directors, with immediate effect.

 

Additionally, Brian James, who has worked with Ironveld since 2012, and has extensive experience in public company reporting, has agreed to take on the role as Acting Group CFO in a non-Board capacity in order to provide support and mentorship over a transitional period of around 12 months, following which it is anticipated that Ms Ratlhagane will become Group CFO.

 

Giles Clarke, Chairman of Ironveld, said: "Following the recent rapid growth in the Company's operations, the Board has decided to establish a more visible financial reporting structure for shareholders going forward, hence the appointment of Malebo as Deputy Group CFO and Brian as Acting Group CFO. As noted, we expect Malebo to become Group CFO after a transitional period of around 12 months."

 

Malebo Ratlhagane has acted as Head of Finance for all of the Ironveld Group's South African entities since 2022 and has been with the Company since 2014. She is a Certified Professional Accountant and a member of the South African Institute of Professional Accountants.

 

Brian James is currently UK Head of Finance for Ironveld Plc and Company Secretary. He is a Chartered Certified Accountant who has acted in senior financial roles for a number of public companies over the last 12 years, including Amerisur Resources where he was employed from 2011 to its sale in January 2020.

 

In due course it is the Board's intention to promote further members of the South African Executive team to ensure that the Plc Board more fully represents the day-to-day operations of the Company and the senior employees.

 

Regulatory disclosures

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Ms Elizabeth Malebo Ratlhagane, aged 39:

Current Directorships

None

Directorships within the past 5 years:

None

At the date of this announcement, Malebo holds options over a total of 3,000,000 new ordinary shares of 0.1 pence each in the Company, representing 0.08 per cent. of the Company's issued share capital.

Ironveld confirms that there are no other disclosures to be made pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies with respect to Ms Malebo Ratlhagane.

 

 

For further information, please contact:

 

Ironveld plc

Martin Eales, Chief Executive Officer

c/o BlytheRay

020 7138 3204

 

 

finnCap (Nomad and Broker)

Christopher Raggett

Charlie Beeson

 

020 7220 0500

 

 

Turner Pope (Joint Broker)

Andy Thacker

James Pope

 

020 3657 0050

BlytheRay

Megan Ray

Tim Blythe

 

020 7138 3204

 

 

NOTES TO EDITORS

 

Ironveld (IRON.LN) is the owner of Mining Rights over approximately 28 kilometres of outcropping Bushveld magnetite with a SAMREC compliant ore resource of some 56 million tons of ore grading 1,12% V2O5, 68,6% Fe2O3 and 14,7% TiO2.

 

In 2022 Ironveld agreed to acquire and refurbish a smelter facility in Rustenburg, South Africa, in which it can process its magnetite ore into the marketable products of high purity iron, titanium slag and vanadium slag. This transaction became unconditional in March 2023.

 

Ironveld is an AIM traded company. For further information on Ironveld please refer to www.ironveld.com.

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAKKAEEDDEFA
Date   Source Headline
24th Jul 20177:00 amRNSCompany Update
10th Jul 20171:29 pmRNSResult of General Meeting
21st Jun 20175:30 pmRNSPlacing, Potential Acquisition and Notice of GM
28th Apr 20177:00 amRNSGranting of Licenses
25th Apr 20172:28 pmRNSBlocklisting Return
11th Apr 20177:00 amRNSPlanned acquisition of smelting business
29th Mar 20177:00 amRNSInterim results for six months ended 31 Dec 2016
2nd Feb 201711:02 amRNSConversion of consultants fees into equity
26th Jan 20174:18 pmRNSTR-1: Notification of Major Interest in Shares
5th Jan 201712:05 pmRNSResult of AGM
21st Dec 201611:06 amRNSNotice of AGM
7th Dec 20167:00 amRNSFinal results for the year ended 30 June 2016
22nd Nov 20167:00 amRNSInvestor evening - 1 December 2016
14th Nov 201611:45 amRNSResult of General Meeting
1st Nov 20167:00 amRNSTotal Voting Rights and Blocklisting Return
26th Oct 20161:21 pmRNSPlacing to raise c.£1.8 million and Notice of GM
6th Oct 20167:00 amRNSProject Finance Facilities and Offtake
2nd Sep 20169:28 amRNSConversion of consultants fees into equity
7th Jun 20167:00 amRNSVanadium Slag Offtake Agreement Signed
20th May 20167:00 amRNSOfftake Agreement and Final Approvals
30th Mar 20167:00 amRNSInterim Results
23rd Mar 201611:06 amRNSHolding(s) in Company
28th Jan 20167:00 amRNSGrant of Share Options
27th Jan 20164:03 pmRNSConversion of Directors' fees into equity
18th Dec 201510:00 amRNSResult of AGM
18th Dec 20157:00 amRNSFinal Approvals and Company Update
23rd Nov 20157:00 amRNSFinal Results
23rd Oct 20157:00 amRNSBlocklisting Return
5th Oct 20157:00 amRNSFunding update & Senior Management Appointment
21st Aug 20153:03 pmRNSHolding(s) in Company
4th Aug 20157:00 amRNSConversion of consultants fees into equity
3rd Aug 20157:00 amRNSOperational Update
9th Jul 20157:00 amRNSConversion of Directors' fees into equity
7th Jul 20157:00 amRNSAppointment of Chief Financial Officer
29th Jun 201510:11 amRNSHolding(s) in Company
22nd Jun 20157:00 amRNSEnvironmental Impact Assessment approved
18th Jun 20157:00 amRNSPlacing and Project Development Update
23rd Apr 20155:30 pmRNSBlocklisting Return
30th Mar 20157:00 amRNSHalf Yearly Report
26th Mar 20157:00 amRNSMining Right Application submitted
19th Mar 20157:00 amRNSDirectorate Change
4th Mar 20157:00 amRNSConversion of consultants fees into equity
2nd Mar 20157:00 amRNSGranting of Mining Right
17th Feb 20157:00 amRNSCritical Infrastructure Programme Application
9th Jan 20155:16 pmRNSConversion of Directors' fees into equity
29th Dec 201411:01 amRNSResult of AGM
15th Dec 20147:00 amRNSHolding(s) in Company
11th Dec 20147:00 amRNSDirector/PDMR Shareholding
9th Dec 20148:46 amRNSDirector's Dealing
5th Dec 20147:00 amRNSFinal Results for 12 Month Period Ended 30/06/2014

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.